Explore the latest in hepatitis B, including recent advances in diagnosis and antiviral treatment, prevention of complications, and more.
This cohort study investigates the association of heavy alcohol intake, aldehyde dehydrogenase 2 gene (ALDH2) rs671 polymorphism, and hepatitis B virus infection with hepatocellular carcinoma development and mortality in patients with cirrhosis.
This cohort study examines the associations of nationwide hepatitis B vaccination and antiviral therapy programs implemented in Taiwan with the burden of end-stage liver disease by age, period, and cohort.
This meta-analysis reconstructs individual participant data from high-quality, propensity score–matched cohort studies and provides more accurate and precise estimates of hepatocellular carcinoma (HCC) risk among patients with chronic hepatitis B virus.
A woman with a history of intravenous heroin use and chronic inactive hepatitis B virus infection had sudden onset of painless jaundice and malaise. Vital signs, mentation, and physical examination were normal except for scleral icterus; she reported no history of travel outside the US and no raw meat ingestion; aminotransferase and bilirubin levels were newly elevated, but she had no acute hepatitis A or C virus infection. What is the diagnosis and what would you do next?
This cross-sectional study assesses characteristics of US decedents with hepatitis B–listed deaths during 2010 to 2019 and compares rates with 2000 to 2009.
This large prospective cohort study compares the rates of acute myocardial infarction between recipients of a 2-dose hepatitis B vaccine and recipients of a 3-dose hepatitis B vaccine.
This cross-sectional study of health claims from patients with private insurance examines trends in the cost of entecavir prescribed for chronic hepatitis B treatment.
A 27-year-old woman presented with elevated transaminase levels and a positive hepatitis B surface antigen test result. How do you interpret these test results?
This randomized clinical trial examines the manufacturing equivalence of a 3-antigen hepatitis B virus (HBV) vaccine and evaluates the noninferiority of its seroprotection rate vs a single-antigen HBV vaccine.
This randomized clinical trial compares the standard hepatitis B virus (HBV) revaccination schedule for patients with HIV vs a regimen with higher doses.
This case-control study examines the association between hepatitis B flare and exposure to Bcr-Abl tyrosine kinase inhibitors (TKIs) compared with non–Bcr-Abl TKIs.
This cohort study examines the trends of hepatocellular carcinoma (HCC) incidence rates and compares rates by risk factors among people in the US and Canada with HIV infection in the combination antiretroviral therapy era.
This JAMA Patient Page reviews the US Preventive Services Task Force’s 2020 recommendation to screen for hepatitis B infection in adolescents and adults at increased risk (B recommendation).
This systematic review to support the 2020 US Preventive Services Task Force Recommendation Statement on screening for hepatitis B virus infection summarizes published evidence on the benefits and harms of screening and interventions for hepatitis B infection in nonpregnant adolescents and adults.
This 2020 US Preventive Services Task Force Recommendation Statement recommends screening for HBV infection in adolescents and adults at increased risk for infection (B recommendation).
This cohort study uses data from the electronic health records of Kaiser Permanente Southern California members to assess whether the number of doses in a hepatitis B virus vaccine series is associated with completion of the series among US adults.
Customize your JAMA Network experience by selecting one or more topics from the list below.